Clinical Trials Browser

Neurofibromatoses × Imatinib Mesylate × Clear all

NCT01140360 2017-07-02

0908-09

Phase 1/2 Completed

21 enrolled 8 charts

Neurofibroma, Neurofibromatoses

NCT00427583 2012-08-07

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Phase 2/3 Terminated

Neurofibromatoses, Nerve Sheath Neoplasms, Neurofibrosarcoma